SDKX and EASTON BIOPHARMACEUTICALS jointly expand the overseas market for Apalutamide tablets

Sinovac Biotech has signed a strategic cooperation agreement with Chengdu Easton Biopharmaceuticals Co., Ltd. Recently, both parties reached an exclusive overseas commercialization authorization for Easton Biopharmaceuticals' Apalutamide tablets in more than ten countries, including Indonesia, Egypt, Saudi Arabia, and Colombia, further deepening their cooperation and promoting this blockbuster drug for prostate cancer treatment in potential markets such as Southeast Asia, the Middle East, and Latin America